aim
better
inform
medic
practition
role
antisept
oropharyng
health
diseas
articl
focus
povidoneiodin
pvpi
establish
widelyavail
antisept
agent
methodolog
review
antiinfect
profil
efficaci
safeti
pvpi
manag
common
upper
respiratori
tract
infect
common
cold
influenza
tonsillopharyng
well
oral
complic
result
cancer
treatment
oral
mucos
dental
condit
periodont
cari
result
antisept
broadspectrum
antiinfect
activ
low
resist
potenti
offer
attract
option
infect
control
prevent
evid
benefit
antisept
varieti
clinic
set
includ
dental
oral
hygien
dermatolog
oncolog
pulmonolog
appear
discord
evidencebas
practic
especi
appar
manag
prevent
oropharyng
infect
use
antisept
vari
consider
clinic
practic
mark
contrast
dermal
applic
extens
use
prophylaxi
treatment
skin
wound
infect
thu
minimis
use
antibiot
conclus
link
oral
oropharyng
health
statu
suscept
infect
long
recognis
high
rate
antibiot
misus
subsequ
develop
bacteri
resist
eg
increas
vancomycinresist
enterococci
vre
methicillinresist
staphylococcu
aureu
mrsa
larg
part
world
especi
across
asia
pacif
highlight
need
identifi
altern
antimicrobi
would
minimis
use
medic
togeth
recent
largescal
outbreak
exampl
avian
swine
influenza
viru
underlin
import
increas
armamentarium
infect
prevent
control
data
collect
pubm
use
specifi
search
criteria
base
efficaci
safeti
microbicid
activ
pvpi
healthbas
search
engin
includ
cochran
librari
also
use
search
review
antisept
use
defin
clinic
set
gener
search
use
googl
nonenglish
articl
pvpi
also
conduct
expert
opinion
sought
area
limit
publish
inform
optim
durat
pvpi
treatment
current
evidencebas
antisept
use
oropharyng
set
per
se
limit
compar
set
studi
pvpi
demonstr
effect
broad
spectrum
common
mouth
throat
pathogen
minimis
risk
upper
respiratori
tract
infect
certain
dental
condit
sever
cancer
therapyassoci
oral
complic
use
pvpi
may
therebi
assist
rationalis
antibiot
prescript
statu
oral
oropharyng
caviti
includ
mouth
throat
inextric
link
gener
health
wellb
individu
colonis
pathogen
microorgan
imbal
physiolog
microbiom
oral
caviti
play
essenti
role
develop
perpetu
diseas
inde
virus
bacteria
fungi
protozoa
give
rise
mani
common
oral
oropharyng
condit
divers
dental
cari
periodont
diseas
gingiv
well
upper
respiratori
tract
infect
sore
throat
common
cold
influenza
hospit
set
colonis
pathogen
oropharyng
region
result
seriou
sequela
intub
patient
spread
lower
respiratori
tract
result
ventilatorassoci
pneumonia
vap
underscor
import
exercis
good
mouth
throat
hygien
mean
minimis
risk
develop
communityacquir
hospitalacquir
infect
oral
complic
known
develop
cancer
patient
either
direct
consequ
malign
side
effect
therapi
appropri
time
oral
care
measur
shown
minimis
sever
complic
improv
patient
qualiti
life
consequ
sever
clinic
guidelin
systemat
review
support
prevent
oral
health
regimen
includ
tooth
brush
use
mouthrins
gargl
profession
oral
care
import
compon
infect
control
practic
antisept
appear
suitabl
candid
altern
adjunct
agent
antibiot
prevent
treat
infect
base
evid
benefit
dental
dermatolog
gener
oral
health
set
current
practic
oropharyng
condit
less
well
establish
object
review
assess
publish
evid
efficaci
safeti
wide
known
antisept
povidoneiodin
polyvinylpyrrolidon
iodin
pvpi
consid
effect
firstlin
option
prevent
manag
skin
infect
common
upper
respiratori
tract
infect
oral
complic
result
cancer
treatment
gener
dental
condit
search
method
includ
electron
databas
pubm
librari
catalogu
cochran
oral
health
group
cochran
ear
nose
throat
disord
group
well
googl
use
combin
search
term
antisept
microbi
clinic
trial
povidoneiodin
oral
health
throat
respiratori
infect
oral
mucos
dental
search
restrict
english
languag
articl
mouth
throat
healthi
individu
known
inhabit
hundr
divers
bacteria
fungi
protozoa
virus
colonis
differ
surfac
oral
oropharyng
caviti
microorgan
may
associ
form
biofilm
resist
antibiot
treatment
mani
microorgan
protect
ecolog
shift
environment
trigger
initi
cascad
event
lead
pathogen
chang
ensu
diseas
inde
transit
asymptomat
healthi
carrier
invas
diseas
reflect
chang
microbi
flora
exact
mechan
chang
unclear
although
poor
oral
hygien
compromis
immun
respons
genet
thought
play
part
interestingli
inflamm
bodi
defenc
injuri
infect
propos
mechan
propag
infect
promot
growth
dysbiot
microbi
commun
evolv
withstand
also
exploit
otherwis
hostil
environ
oral
oropharyng
caviti
act
reservoir
broad
varieti
potenti
pathogen
microorgan
tabl
indic
need
antisept
agent
broadspectrum
activ
well
oral
formul
ensur
whole
oral
oropharyng
antisept
coverag
povidoneiodin
consid
broadest
spectrum
antimicrobi
action
compar
common
antisept
chlorhexidin
octenidin
polyhexanid
hexetidin
show
efficaci
gramposit
gramneg
bacteria
bacteria
spore
fungi
protozoa
sever
virus
persist
effect
also
demonstr
studi
assess
pvpi
preprocedur
antibacteri
agent
individu
vari
degre
oral
hygien
reduct
microorgan
concentr
found
sustain
least
h
furthermor
evid
pvpi
abl
restor
natur
microbi
flora
follow
bacteri
infect
observ
set
bacteri
vaginosi
prospect
randomis
clinic
trial
women
bacteri
vaginosi
treatment
pvpi
led
rapid
recolonis
nativ
lactobacilli
studi
use
gargl
mouthwash
sampl
healthi
volunt
pvpi
found
elicit
stronger
bactericid
activ
methicillinresist
staphylococcu
aureu
mrsa
pseudomona
aeruginosa
benzethonium
chlorid
bec
chlorhexidin
glucon
chg
pvpi
also
shown
vitro
effect
highli
resist
enterococcu
faecium
well
coagulaseneg
staphylococci
strain
proteu
serratia
pseudomona
variou
mycobacteria
strain
moreov
studi
compar
bactericid
activ
pvpi
gargl
chg
cetylpyridinium
gargl
isol
standard
strain
gramposit
mrsa
gramneg
bacteria
p
aeruginosa
klebsiella
pneumonia
pvpi
found
elicit
rapid
kill
three
strain
exposur
dilut
contrast
chlorhexidin
chg
fail
kill
strain
timepoint
dilut
cetylpyridinium
chlorid
cpc
found
effect
gramneg
strain
exposur
hexetidin
shown
smaller
antimicrobi
spectra
pvpi
even
chg
consid
less
effect
reduc
burden
dental
plaqu
bacteria
chg
anoth
compar
studi
bactericid
activ
pvpi
bec
gargl
bordetella
povidoneiodin
report
highest
virucid
activ
profil
among
sever
antisept
chg
benzalkonium
chlorid
bac
bec
alkyldiaminoethylglycin
hydrochlorid
aeg
use
standardis
vitro
approach
pvpi
gargl
found
inactiv
panel
virus
includ
adenoviru
mump
rotaviru
polioviru
type
coxsacki
viru
rhinoviru
herp
simplex
viru
rubella
measl
influenza
human
immunodefici
viru
studi
chg
bac
bec
aeg
ineffect
adenoviru
polio
viru
rhinoviru
gener
show
activ
aforement
virus
recent
studi
pvpi
product
includ
gargl
throat
spray
demonstr
rapid
virucid
activ
highli
pathogen
low
pathogen
strain
avian
influenza
virus
viral
titr
fall
detect
limit
assay
pvpi
incub
similarli
formul
also
show
efficaci
sever
acut
respiratori
syndrom
coronaviru
strain
pvpi
mediat
rapid
inactiv
viru
min
treatment
furthermor
result
studi
confirm
virucid
efficaci
pvpi
product
includ
pvpi
gargl
swine
influenza
virus
povidoneiodin
also
shown
rapid
activ
candida
speci
vitro
rang
contact
kill
time
candida
albican
major
opportunist
pathogen
caus
recurr
oral
thrush
oropharyng
candidiasi
particular
problem
hivaid
patient
requir
expens
treatment
antifung
medic
pvpi
shown
highli
activ
speci
use
report
reduc
medic
cost
associ
fungal
infect
taken
togeth
data
support
vitro
efficaci
pvpi
erad
broad
rang
pathogen
microorgan
like
play
aetiolog
role
develop
common
oral
infect
activ
moieti
non
pvpbound
free
iodin
releas
solut
pvpi
complex
pvp
microbicid
activ
rather
deliv
free
iodin
target
cell
membran
free
iodin
mediat
basic
mechan
action
oxid
amino
acid
nucleic
acid
biolog
structur
difficult
imposs
counteract
basic
mechan
action
lead
strong
microbicid
activ
express
multipl
mode
action
includ
disrupt
microbi
metabol
pathway
well
destabilis
structur
compon
cell
membran
caus
irrevers
damag
pathogen
consum
free
iodin
replac
pvpbound
iodin
concentr
free
iodin
determin
factor
microbicid
action
pvpi
pvpi
exposur
lead
destruct
cytosol
nuclear
structur
bacteria
damag
cell
wall
fungi
studi
investig
virucid
activ
differ
disinfect
electron
micrograph
reveal
exposur
iodin
led
degener
nucleoprotein
viral
particl
main
mechan
action
howev
disrupt
surfac
protein
essenti
spread
envelop
virus
also
note
addit
direct
kill
action
bacteria
pvpi
also
inhibit
releas
pathogen
factor
exotoxin
endotoxin
tissuedestroy
enzym
furthermor
iodin
scaveng
free
radic
oxygen
speci
contribut
antiinflammatori
properti
given
issu
antibiot
resist
critic
characterist
antisept
one
low
resist
potenti
extens
review
literatur
clinic
report
microbi
resist
develop
respons
pvpi
treatment
like
due
action
multipl
pathogen
target
contrast
bacteri
resist
chlorhexidin
document
resist
may
result
alter
bacteri
suscept
part
alter
outer
membran
gramneg
bacteria
prevent
antisept
adsorpt
gene
confer
resist
chlorhexidin
quaternari
ammonium
compound
identifi
aureu
isol
europ
japan
report
crossresist
antisept
pvpi
remain
unaffect
upper
respiratori
tract
infect
urti
one
common
reason
present
primari
practic
adult
children
major
caus
mild
morbid
symptom
rang
common
cold
cough
pharyng
fever
occasion
seriou
complic
associ
high
societ
cost
due
loss
product
absente
school
medic
resourc
urti
caus
virus
adenoviru
rhinoviru
influenza
coxsackieviru
herp
simplex
viru
coronaviru
respiratori
simplex
viru
howev
current
practic
often
consid
aetiolog
basi
urti
lead
inappropri
antibiot
prescript
urti
viral
origin
particularli
evid
treatment
pharyng
sore
throat
case
bacteri
infect
inappropri
overus
antibiot
reinforc
import
identifi
altern
antiinfect
agent
complement
physic
barrier
intervent
eg
handwash
wear
mask
prevent
interrupt
spread
respiratori
pathogen
first
step
develop
urti
adher
colonis
respiratori
pathogen
oropharyng
mucosa
assum
oral
entri
pathogen
gargl
offer
practic
measur
erad
gargl
strongli
advoc
prevent
treatment
urti
japan
practic
support
find
studi
look
role
gargl
healthi
individu
frequent
persist
respiratori
infect
studi
gargl
either
water
pvpi
four
time
daili
respect
found
reduc
incid
urti
furthermor
patient
experienc
chronic
respiratori
infect
pvpi
found
reduc
episod
infect
p
aeruginosa
aureu
includ
mrsa
h
influenza
half
find
corrobor
nonrandomis
studi
gargl
dilut
pvpi
reduc
incid
influenzalik
ill
common
cold
subsequ
absente
school
work
place
mechan
gargl
prevent
respiratori
infect
requir
investig
earli
studi
suggest
gargl
may
lead
remov
oralpharyng
hous
dust
mite
proteas
shown
increas
infect
influenza
viru
gargl
intensifi
presenc
pvpi
may
therefor
play
import
role
prevent
reduct
incid
infect
droplet
transmiss
inde
benefit
gargl
pvpi
note
japanes
clinic
respiratori
guidelin
recommend
gargl
pvpi
four
time
day
inpati
healthcar
worker
prevent
hospitalacquir
pneumonia
pvpi
also
recommend
prevent
measur
pandem
influenza
bactericid
activ
pvpi
gargl
explor
studi
children
attend
middl
school
japan
effect
absente
cold
influenza
assess
mean
reduct
rate
bacteri
count
immedi
gargl
pvpi
vs
chg
cpc
respect
furthermor
effect
reduct
bacteria
count
pvpi
correl
lower
absenc
rate
cold
influenza
compar
school
use
gargl
encourag
respiratori
infect
hospit
set
aspir
pneumonia
vap
major
issu
especi
elderli
peopl
immunocompromis
patient
associ
high
rate
mortal
moreov
individu
gastrooesophag
reflux
diseas
develop
recurr
chronic
aspir
pneumonia
aspir
gastric
content
lung
pneumonia
also
common
patient
mechani
cal
ventil
result
aspir
salivari
bacteria
lower
respiratori
tract
prospect
randomis
studi
efficaci
pvpi
rins
preval
vap
patient
sever
head
trauma
expect
need
ventil
assess
compar
receiv
salin
control
rins
significantli
fewer
patient
pvpi
group
p
respect
develop
vap
anoth
randomis
studi
efficaci
pvpi
mechan
chemic
prophylact
oral
cleans
reduc
oral
respiratori
pathogen
patient
requir
endotrach
intub
assess
clean
pvpi
result
signific
reduct
microbi
count
pneumonia
p
h
influenza
p
separ
studi
assess
prophylact
use
pvpi
gargl
reduc
risk
nosocomi
pneumonia
pvpi
found
erad
gener
bacteria
mrsa
coloni
pharynx
intub
tip
tube
extub
studi
provid
strong
rational
use
pvpi
effect
oral
care
measur
reduc
burden
potenti
pathogen
minimis
risk
infect
communityacquir
hospitalacquir
set
oral
mucos
om
common
debilit
complic
cancer
therapi
affect
patient
undergo
radiotherapi
head
neck
malign
patient
undergo
chemotherapi
signific
associ
mucos
develop
seriou
clinic
outcom
pain
infect
impair
nutrit
statu
weight
loss
observ
importantli
symptom
lead
disrupt
cancer
therapi
retrospect
sampl
patient
solid
tumour
lymphoma
develop
chemotherapyinduc
myelosuppress
episod
infect
significantli
common
cycl
om
grade
cycl
without
om
vs
respect
directli
proport
sever
om
pathogenesi
oral
mucos
involv
direct
indirect
mechan
direct
mucos
injuri
radiat
chemotherapi
interfer
averag
turnov
time
oral
epithelium
induc
apoptosi
indirect
stomatotox
effect
result
releas
inflammatori
mediat
loss
protect
salivari
constitu
therapyinduc
neutropenia
postul
contribut
develop
oral
mucos
also
promot
emerg
bacteria
fungi
virus
damag
mucosa
sever
studi
demonstr
mainten
good
oral
hygien
prophylact
therapeut
approach
reduc
sever
om
oral
decontamin
may
assist
reduc
bacteraemia
infect
opportunist
pathogen
masccisoo
guidelin
recommend
combin
toothbrush
floss
least
one
mouth
rins
efficaci
pvpi
prepar
radiationinduc
om
explor
numer
studi
reduct
onset
week
vs
week
p
sever
mean
grade
vs
p
durat
week
vs
week
p
oral
mucos
demonstr
pvpi
use
four
time
daili
part
standard
prophylact
mucos
regimen
compar
standard
regimen
nystatin
dexpanthenol
rutosid
immunoglobulin
alon
similarli
pvpi
use
multiag
mouthrins
incid
sever
om
reduc
therefor
legitim
specul
antiinflammatori
properti
support
antimicrobi
characterist
pvpi
om
treatment
randomis
control
trial
effect
three
mouthwash
includ
pvpi
chlorhexidin
saltsodium
bicarbon
assess
patient
head
neck
malign
undergo
radiationinduc
oral
mucos
pvpi
significantli
reduc
mucos
score
first
week
radiotherapi
compar
control
group
week
mucos
score
patient
treat
pvpi
significantli
lower
salt
sodium
bicarbon
group
chlorhexidin
group
respect
find
support
systemat
review
assess
effect
commonli
use
mouthwash
prevent
treatment
chemotherapyinduc
oral
mucos
benefici
effect
chlorhexidin
note
pvpi
found
reduc
sever
om
much
compar
steril
water
specif
recommend
use
mouthwash
prevent
oral
mucos
masccisoo
guidelin
neither
use
chlorhexidin
antimicrobi
lozeng
recommend
om
prevent
patient
undergo
radiotherapi
furthermor
chlorhexidin
recommend
treatment
establish
om
recommend
base
conflict
trial
result
insuffici
evid
respect
role
pvpi
oral
surgeri
dental
condit
addit
broadspectrum
microbi
activ
low
potenti
resist
pvpi
also
demonstr
haemostypt
antiinflammatori
effect
minor
oral
surgeri
singleblind
randomis
studi
alveolar
socket
patient
follow
tooth
extract
irrig
either
pvpi
plu
salin
salin
alon
significantli
patient
pvpi
group
experienc
spontan
bleed
cessat
control
group
p
studi
highlight
first
time
haemostat
action
pvpi
effect
demonstr
prospect
pilot
studi
assess
time
optim
haemostasi
patient
undergo
periap
surgeri
singleroot
maxillari
anterior
tooth
lesion
compar
salin
pvpi
use
irrig
periap
surgic
field
cotton
signific
reduct
time
bleed
cessat
apex
p
also
mark
reduct
visual
analogu
scale
score
oedema
first
two
postop
day
use
nonsteroid
antiinflammatori
drug
efficaci
pvpi
antioedemat
agent
also
evid
randomis
control
clinic
trial
patient
undergo
mandibular
third
molar
remov
split
mouth
design
assess
postop
effect
pvpi
mgml
use
irrig
coolant
signific
decreas
swell
trismu
observ
compar
salin
control
p
signific
differ
observ
pain
score
treatment
group
similar
observ
report
anoth
studi
reduc
postop
swell
pvpi
attribut
inhibitori
effect
leukotrien
leucocyt
extravas
use
pvpi
prophylact
measur
dental
surgeri
also
demonstr
preprocedur
rins
pvpi
shown
reduc
level
microorgan
gener
aerosol
spatter
dental
procedur
rotari
instrument
although
larg
prevent
common
oral
diseas
affect
gener
popul
dental
cari
periodont
diseas
children
sever
earli
childhood
cari
pvpi
led
signific
reduct
p
major
cariogen
bacterium
streptococcu
mutan
postop
baselin
level
month
oral
rehabilit
reduct
bacteri
count
subsequ
result
decreas
cari
relaps
defin
presenc
one
new
smooth
surfac
cari
lesion
primari
tooth
data
support
earlier
evid
effect
pvpi
prevent
dental
cari
highrisk
children
requir
gener
anaesthesia
oral
rehabilit
efficaci
pvpi
also
assess
set
periodont
gingiv
systemat
review
chronic
periodont
pvpi
adjunct
scale
root
plane
report
small
signific
benefici
effect
enhanc
probe
pocket
depth
reduct
use
pvpi
adjunct
nonsurgeri
therapi
use
ultrason
devic
retreat
patient
longterm
manag
advanc
periodont
demonstr
shown
result
improv
gingiv
condit
reduc
probe
pocket
depth
signific
reduct
probe
attach
level
loss
year
separ
studi
pvpi
combin
hydrogen
peroxid
adjunct
normal
oral
hygien
led
mark
reduct
baselin
gingiv
inflamm
reflect
lower
plaqu
papillari
bleed
score
water
compar
week
use
pvpi
also
shown
extend
manag
odontogen
deep
fascial
space
infect
dentoalveolar
abscess
role
pvpi
endodont
practic
also
report
two
studi
assess
effect
rang
antisept
includ
pvpi
rapid
decontamin
guttapercha
cone
artifici
contamin
bacteri
cell
spore
demonstr
bactericid
effect
staphylococcu
aureu
escherichia
coli
e
faecali
bacillu
subtili
spore
approxim
min
follow
pvpi
treatment
rapid
decontamin
also
demonstr
separ
studi
treatment
pvpi
found
effici
recent
applic
pvpi
artifici
biofilm
two
periodont
pathogen
porphyromona
gingivali
fusobacterium
nucleatum
show
effect
suppress
microbi
constitu
concentr
indic
daili
oral
rins
notabl
periodont
pathogen
p
gingivali
actinobacillu
actinomycetemcomitan
transmit
within
famili
member
periodont
treatment
therefor
involv
elimin
signific
suppress
pathogen
diseas
individu
high
standard
oral
hygien
find
reinforc
recommend
preprocedur
mouth
rins
patient
undergo
dental
procedur
assist
reduct
oral
bacteria
load
particularli
import
consider
patient
atrisk
bacteri
endocard
importantli
shortterm
use
pvpi
shown
irrit
healthi
diseas
oral
mucosa
exhibit
advers
effect
discolor
teeth
tongu
chang
tast
studi
report
absenc
irrit
damag
oral
mucosa
pvpi
rins
period
week
discolor
composit
restor
observ
children
receiv
pvpi
solut
follow
dental
rehabilit
almost
year
market
safeti
profil
pvpi
wellestablish
although
measur
system
absorpt
may
occur
longterm
use
pvpi
clinic
manifest
thyroid
dysfunct
common
previou
studi
report
pvpi
mouthwash
use
four
time
daili
short
period
week
oncedaili
prolong
period
week
affect
thyroid
function
howev
increas
serum
thyroid
stimul
hormon
concentr
may
occur
prolong
pvpi
treatment
week
may
benefit
drug
holiday
allow
serum
tsh
level
return
baselin
level
pvpi
therefor
use
hyperthyroid
diseas
thyroid
addit
use
pvpi
gargl
use
pregnanc
lactat
strictli
indic
kept
absolut
minimum
pvpi
found
favour
toler
children
receiv
pvpi
dental
condit
gener
shown
time
better
toler
common
antisept
case
allerg
dermat
prolong
skin
contact
pvpi
report
consid
rare
complic
differ
local
pruritu
skin
irrit
overal
allergen
profil
pvpi
compar
well
antisept
clinic
practic
perspect
choic
appropri
antisept
product
topic
oral
use
like
depend
oropharyng
site
diseas
infect
well
activ
ingredi
patient
prefer
lozeng
analges
anaesthet
properti
becom
increasingli
popular
use
urti
exampl
percept
throat
sweet
may
lead
unintent
dose
larg
welldesign
randomis
clinic
trial
consid
gold
standard
assess
treatment
intervent
howev
find
limit
applic
patient
clinic
practic
like
heterogen
pvpi
number
studi
requir
variou
oropharyng
condit
possibl
compar
make
impract
task
nevertheless
sever
studi
includ
vitro
realworld
smallscal
randomis
studi
pvpi
provid
evid
efficaci
prevent
treat
common
oral
oropharyng
disord
benefit
pvpi
reflect
broadspectrum
antiinfect
profil
low
potenti
resist
well
haemostat
antiinflammatori
properti
furthermor
pvpi
avail
differ
strength
formul
pvpi
gargl
mouthwash
across
asia
eg
japan
also
avail
throat
spray
wv
formul
therebi
allow
flexibl
dose
regimen
suit
individu
patient
need
regimen
length
pvpi
use
depend
condit
treat
prevent
well
suscept
offend
microorgan
toward
pvpi
clearli
desir
effect
concentr
solut
time
exposur
need
balanc
patient
complianc
motiv
essenti
especi
longer
gargl
rins
time
necessari
gener
gargl
rins
ml
undilut
pvpi
follow
minimum
appropri
treatment
prevent
sore
throat
prophylact
use
surgeri
longer
rins
min
suggest
treatment
exist
mouth
lesion
oral
mucos
rins
mouth
undilut
pvpi
min
meal
consid
optim
given
potenti
pvpi
reduc
incid
airborn
droplettransmit
respiratori
infect
eg
sar
avian
flu
swine
flu
undilut
pvpi
use
protect
measur
rins
mouth
min
four
time
day
pvpi
also
use
part
routin
hygien
practic
gargl
follow
rins
mouth
use
ml
dilut
undilut
mouthwash
suggest
pvpi
gargl
mouthwash
dilut
defin
clinic
set
done
patient
care
instruct
proper
dilut
strongli
advis
formal
studi
assess
optim
length
treatment
pvpi
gargl
mouthwash
clinic
practic
expert
opinion
suggest
day
urti
week
oral
mucos
oncolog
set
patient
laryng
cancer
undergo
radiotherapi
typi
calli
treat
pvpi
week
nasopharyng
cancer
patient
recommend
pvpi
week
antisept
pvpi
address
challeng
mani
clinic
set
infecti
condit
must
prevent
treat
mediat
localis
effect
spare
prevent
use
antibiot
provid
viabl
option
therapeut
armamentarium
common
oropharyng
infect
